CAS: 148461-15-8; (S)-2-(2-(Diphenylphosphino)Phenyl)-4-Phenyl-4,5-Dihydrooxazole
- 英文名称(S)-2-(2-(Diphenylphosphino)Phenyl)-4-Phenyl-4,5-Dihydrooxazole
- 中文名称(S)-(+)-2-[2-(二苯基膦)苯基]-4-苯基-2-噁唑啉
- IUPAC名称(S)-2-(2-(diphenylphosphaneyl)phenyl)-4-phenyl-4,5-dihydrooxazole
- 其它别名(S)-Ph-Phox; (S)-2-(2-(Diphenylphosphino)Phenyl)-4-Phenyl-4,5-Dihydrooxazole; S(+)-2-[2-(Diphenylphosphino)Phenyl]-4-Phenyl-2-Oxazoline; (4S)-2-[2-(Diphenylphosphanyl)Phenyl]-4-Phenyl-4,5-Di
- CAS编号148461-15-8
- MFCD编号:MFCD01863026
- 分子式:C27H22NOP
- 分子量:407.44
- 产品CID: 712428
- 产品分类化学试剂 → 有机试剂 → 膦配体
物理性质
MSDS等安全信息
上下游产品
(4S)-2-(2-fluorophenyl)-4-phenyl-1,3-oxazoline potassium diphenylphosphine 2-(diphenylphosphanyl)benzonitrile (2S)-2-phenylglycinol合成工艺路线路线简述
2-氟苯腈置于zinc(II) Chloride体系中,用 四氢呋喃,氯苯 用作溶剂,化学反应 50.0H,反应生成(S)-(+)-2-[2-(二苯基膦)苯基]-4-苯基-2-噁唑啉
参考文献:新型含硫和磷的恶唑啉作为配体的不对称催化反应
标题:新型含硫和磷的恶唑啉作为配体的不对称催化反应
摘要:描述了同时包含恶唑啉基团和另外的硫或磷供体原子的对映体纯的配体的制备.一步法制得了甲硫基甲基,邻硫代茴香基和噻吩基恶唑啉,并分两步从可商购的起始原料中以高收率制备了邻二苯基膦基苯基恶唑啉.
Doi:10.1016/s0040-4020(01)80795-X
海关参考信息
- 2902600000-乙苯
2906210000-苄醇
2922110001-单乙醇胺
2909199090-其他醚及其衍生物 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-8629134-B2
优先权日:2007-02-01
标题:Enantioselective synthesis of 6-amino-7-hydroxy-4,5,6,7-tetrahydro-imidazo[4,5,1-jk][1]-benzazepin-2[1H]-one and zilpaterol
发明人：ALMENA-PEREA JUAN JOSE; BRINK MONIKA; GEIBETA GERHARD; KADYROV RENAT; MEYER THORSTEN
权利人:ALMENA-PEREA JUAN JOSE; BRINK MONIKA; GEIBETA GERHARD; KADYROV RENAT; MEYER THORSTEN; INTERVET INT BV
摘要:This invention relates to a process for the hydrogenation of a ketooxime to selectively form an aminoalcohol stereoisomer, and, in particular, to a process for the hydrogenation of 4,5-dihydro-imidazo[4,5,1-jk][1]benzazepin-2,6,7[1H]-trione-6-oxime or a salt thereof to selectively form a stereoisomer of 6-amino-7-hydroxy-4,5,6,7-tetrahydro-imidazo[4,5,1-jk][1]-benzazepin-2[1H]-one or a salt thereof. This invention also relates to the use of the 6-amino-7-hydroxy-4,5,6,7-tetrahydro-imidazo[4,5,1-jk][1]-benzazepin-2[1H]-one hydrogenation product or a salt thereof to selectively make a stereoisomer of zilpaterol or a salt thereof, as well as the use of such a zilpaterol stereoisomer or salt in methods of treatment and medicaments for animals.
专利号:US-2006199974-A1
优先权日:2005-02-22
标 题:Process for the synthesis of enantiomeric indanylamine derivatives
专利号:EP-2109614-B1
优先权日:2007-02-01
标题:Enantioselective synthesis of 6-amino-7-hydroxy-4, 5, 6, 7-tetrahydro-imidazo [4, 5, 1-jk][1]-benzazepin-2 [1h]-one and zilpaterol
专利号:US-2010173892-A1
优先权日:2007-02-01
标题:Enantioselective synthesis of 6-amino-7-hydroxy-4,5,6,7-tetrahydro-imidazo[4,5,1-JK][1]-benzazepin-2[1H]-one and zilpaterol
网址: http://www.krl-tech.com
企业联系电话：0512-66834346👤
地址:合肥市高新区孔雀台路习友路口国家健康大数据产业园C2-01栋
企业联系电话：0512-66834346👤
📞安徽凯泰莱铂科技有限公司 ⚠️参考联系方式
联系人：郑朝晖
电话：0512-66834346
手机：17751128648
邮箱：13916109676@163.com
通信地址: 合肥市高新区孔雀台路习友路口国家健康大数据产业园C2-01栋
邮编: 230041
电话：0512-66834346
手机：17751128648
邮箱：13916109676@163.com
通信地址: 合肥市高新区孔雀台路习友路口国家健康大数据产业园C2-01栋
邮编: 230041
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领，请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实，百琢研不参与任何交易。企业认领注册入口→
地址:合肥市高新区孔雀台路习友路口国家健康大数据产业园C2-01栋
⚠️ 未注册 · 未认证企业
备注: 📌 数据来源说明：本展台内容基于各搜索引擎等公开数据整理，仅作展示用途。请用户自行辨别✉️ 若企业需抹除展台内容或有异议， 请通过页面底部联系方式告知我们，我们会尽快处理。
第 1 / 1 页
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
主要参考文献
参考标题:Phosphination Of Phenol Derivatives And Applications To Divergent Synthesis Of Phosphine Ligands作者:Chenchen Li,Kezhuo Zhang,Minghao Zhang,Wu Zhang,Wanxiang Zhao |发布日期:2021.11.19
摘要:Describe A General And Efficient Protocol For The Synthesis Of Organophosphine Compounds From Phenols And Phosphines (R2Ph) Via A Metal-Free C-O Bond Cleavage And C-P Bond Formation Process. This Approach Exhibits Broad Substrate Scope And Excellent Functional Group Tolerance. The Synthetic Utilities Of This Protocol Were Demonstrated By The Synthesis Of Chiral Ligands Via The Various Transformations
合成参考文献
摘要:Zhang, X.; You, S.-L., Science of Synthesis: Metal-Catalyzed Cyclization Reactions, (2016) 1, 96.
📝 需求与反馈
尽可能描述清楚需求与问题信息
